UTI LIMITED PARTNERSHIP Patent applications |
Patent application number | Title | Published |
20160073931 | FOOT MORPHOMETRIC MEASURING DEVICE - A foot measuring device and method measure foot last/curvature, foot width, foot length, arch height, foot volume, first metatarsophalangeal (MTP) joint flexibility and standing rear foot pronation. The foot measuring device includes a base having a heel abutment member, a foot size and alignment graphic, an arch height measurement system, and a MTP joint flexibility measurement lever. | 03-17-2016 |
20150289992 | APPARATUS AND METHOD FOR POSITIONING OF ACETABULAR COMPONENTS DURING HIP ARTHROPLASTY PROCEDURES - The present disclosure pertains to apparatus and methods for positioning the angular orientation and depth positioning of an acetabular component during hip arthroplasty procedures. The apparatus comprises a positioning member and guiding member set according to a preoperatively determined angular orientation derived from a pelvic radiograph or radiographs in accordance with the methods provided. | 10-15-2015 |
20150259754 | DROPLET-BASED MICROFLUIDIC DEVICE HAVING A PLURALITY OF REACTION SITES - The present invention provides a droplet-based microfluidic device comprising a passivating top surface and methods for producing and using the same. In particular, the passivating surface comprises of a nano-textured superhydrophobic material. | 09-17-2015 |
20150250871 | METHODS AND COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS AND RELATED DISORDERS - This disclosure provides therapeutic compositions and methods for treating multiple sclerosis or a multiple sclerosis-related disorder in a subject in need thereof comprising administering an effective amount of an antigen-MHC-nanoparticle complex to the subject, wherein the antigen is a multiple sclerosis-related antigen. | 09-10-2015 |
20150231203 | TREATMENT OF PAIN BY INHIBITION OF USP5 DE-UBIQUITINASE - The invention provides methods treating pain by inhibiting a Cav3.2 channel expression or function, including the use of contacting said channel in situ with an inhibitor of USP5 or an inhibitor of the interaction between Cav3.2 and USP5. | 08-20-2015 |
20150209446 | METHODS AND COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS AND RELATED DISORDERS - This disclosure provides therapeutic compositions and methods for treating multiple sclerosis or a multiple sclerosis-related disorder in a subject in need thereof comprising administering an effective amount of an antigen-MHC-nanoparticle complex to the subject, wherein the antigen is a multiple sclerosis-related antigen. | 07-30-2015 |
20150150544 | Apparatuses and Methods for Endoscope and/or With Tool Actuated by Shape Memory Alloy Element - Apparatuses and methods for capsule endoscopes with tools actuated by a combination of a shape memory alloy (SMA) element and a biasing element (e.g., spring). Apparatuses and methods for biopsies actuated by an SMA element. | 06-04-2015 |
20150134288 | DECOMPOSITION OF NEAR-FIELD REFLECTIONS - Systems and methods for decomposition of near-field reflections are presented. In an embodiment, a method may include identifying data associated with a reference signal in a reflection-based imaging device. The method may also include identifying shifted and scaled versions of the reference signal in reflection data gathered by the reflection-based imaging device. Additionally, the method may include solving a time-of-arrival and a scaling factor of the reference signal with a non-linear optimization. | 05-14-2015 |
20150099668 | METABOLITE BIOMARKERS FOR STAGING COLORECTAL CANCER - This document provides methods and materials for assessing metabolites in a sample from a mammal (e.g., human) for determining the nature and extent of colorectal cancer (CRC) metastasis. For example, the document relates to the diagnosis, staging and prognosis of CRC in a mammal. | 04-09-2015 |
20150065414 | MODIFIED TOLL-LIKE RECEPTOR 2 (TLR2) LIGANDS AS INHIBITORS OF NEUTROPHIL RECRUITMENT - The present invention provides modified TLR2 ligands useful for modulating inflammatory responses. In particular, the ligands comprise (a) a fatty acid di- or tri-linoleate and (b) a GM1-binding peptide. The linoleate provides the anti-inflammtory function, while the GM1-binding peptide facilitates endocytosis. | 03-05-2015 |
20150032176 | GASTROINTESTINAL MOTILITY CONTROL - A method and a multichannel implantable device are described for partial or complete restoration of impaired gastrointestinal motility, or for disturbing and/or partially or completely blocking normal gastrointestinal motility using one or multiple microsystem-controlled channels of circumferentially arranged sets of two or more electrodes which provide externally-invoked synchronized electrical signals to the smooth muscles via the neural pathways. | 01-29-2015 |
20140378657 | STREPTAVIDIN MUTEIN EXHIBITING REVERSIBLE BINDING FOR BIOTIN AND STREPTAVIDIN BINDING PEPTIDE TAGGED PROTEINS - The present invention relates to a new streptavidin muteins. This mutein is binds both streptavidin binding peptide tagged and biotin or biotinylated molecules, and does so in a reversible fashion. As such, it is stable enough to allow reuse, and producible with reasonable production yield via secretion in a soluble functional state without the requirement of refolding via the tedious and expensive denaturation and renaturation processes. | 12-25-2014 |
20140377220 | GENE EXPRESSION SIGNATURES FOR STAGING AND PROGNOSIS OF PROSTATE, BREAST AND LEUKEMIA CANCERS - The present invention is drawn to methods of assessing and treating cancers such as ERG-related, prostate, breast and leukemia, by examining the expression of combinations of particular genes disregulated in this disease state. The combinations of genes are selected from the following genes: inhibitor of growth family, member 3 (HSTG3); lymphoid enhancer-binding protein factor 1 (LEF1); frizzled-related protein (FRZB); annexin A4 (ANXA4); Meis homeobox 2 (MEIS2); syndecan binding protein (syntenin) (SDCBP); ankyrin 3, node of Ranvier (ankyrin G) (ANK3); chromodomain helicase DNA binding protein 5 (CHD5); phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) (PLA2G7); and wingless-type MMTV integration site family member 2 (WNT2). | 12-25-2014 |
20140301949 | OXYGENATION PROCEDURES FOR NEWBORNS AND DEVICES FOR USE THEREIN - The present invention relates to methods and systems for resuscitation of an infant which maintains healthy blood oxygen saturation values in the infant by titration of supplemental oxygen concentrations. | 10-09-2014 |
20140299745 | APPARATUS, SYSTEM, AND METHOD FOR EMISSION FILTER - An apparatus, system, and method for emission filter. A filter apparatus is presented. In one embodiment, the filter apparatus may be adapted for fluorescence spectroscopy. In a particular embodiment, the filter apparatus comprises a solution. The solution may include a polar protic solvent and an absorbing specimen. Additionally, the filter apparatus may include an adhesive to conform the solution into a solid filter. | 10-09-2014 |
20140247186 | Global Navigation Satellite System (GNSS) Anti-Interference using Array Processing - Embodiments of the invention are directed to GNSS anti-interference using array processing. In one embodiment, a device may be configured to receive signals GNSS signals. In one embodiment, the signals may include a superposition of GNSS signals from independent transmitter sources and a spoofing signal. The spoofing signal may include several pseudo random noise (PRN) codes originating from a single transmitter source. In a one embodiment, the device may include multiple radio frequency (RF) inputs connected to multiple antennas and may use a combining algorithm to produce a weighted sum of the antenna outputs. The resultant sum may be passed through an output port of the device that is configured to be coupled to an RF input port of a GNSS receiver. | 09-04-2014 |
20140206870 | FLUORSCENT DYES WITH LARGE STOKES SHIFTS - Herein are disclosed fluorescent dyes based around a framework for a ligand comprising a pyridyl group linked to a diaryl anilido unit. A variety of ligands based on this framework are disclosed. The ligands chelate to a BF | 07-24-2014 |
20140205591 | Metabolite Biomarkers for Diagnosis and Prognosis of Pediatric Septic Shock - The present invention provides methods for differentiating a pediatric subject with pediatric septic shock from a healthy pediatric subject or one having sudden inflammatory response syndrome (SIRS). Also provided is a method of predicting pediatric septic shock mortality in a pediatric septic shock patient. | 07-24-2014 |
20140188000 | Methods and Apparatuses for Full-Thickness Hollow Organ Biopsy - A method for obtaining a full thickness biopsy of the wall of a hollow organ, comprising obtaining an apparatus comprising a cannula comprising a proximal cannula end comprising a cutting edge; and a distal cannula end comprising a biased spring, the biased spring being coupled to a needle carrier and a releasable lock; and a needle disposed within the cannula and carried on the needle carrier, the needle comprising: a tip; a flange; a notch portion comprising a notch thickness; and a shaft comprising a shaft thickness; where the shaft thickness is greater than the notch thickness and the releasable lock is configured to hold the cannula in a withdrawn position relative to the needle; obtaining a patient having skin, a first wall, and a second wall; creating an incision through the skin of the patient; inserting the apparatus into the incision; advancing the apparatus through the first wall and the second wall; withdrawing the cannula relative to the needle; locking the cannula with the releasable lock; aligning the notch portion such that the notch portion straddles the second wall; releasing the releasable lock such that the cutting edge of the cannula passes completely through the second wall creating a full-thickness biopsy; and withdrawing the apparatus from the patient. | 07-03-2014 |
20130344510 | IDENTIFICATION OF CANCER PATIENTS LIKELY TO BENEFIT FROM RADIATION THERAPY - Disclosed herein are methods of identifying suitable patients for postoperative radiotherapy based on the discovery that the quantification of ER, beyond simple positive/negative characterization, can provide valuable predictive information for the treatment of cancer, specifically breast cancer, and more particularly may predict a group more likely to respond to RT and spare patients from a potentially harmful treatment. Furthermore, the true quantification of ER expression provides a continuous recurrence risk assessment for patients being treated with tamoxifen, and therefore the standardization of the data across sites and imaging platforms significantly reduces the misclassification of patients when compared to the current standard by which ER expression is determined. | 12-26-2013 |
20130330414 | METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION - This disclosure provides therapeutic compositions and methods for inducing an anti-inflammatory response and/or treating inflammation in the gastrointestinal tract and/or accumulating gut microbial antigen-specific anti-inflammatory T cells in a patient in need thereof. | 12-12-2013 |
20130162473 | DUAL CIRCULARLY POLARIZED ANTENNA - An antenna includes a waveguide having an aperture at a first end and a conducting component at a second end, the conducting component shorting the waveguide and a first set of two orthogonal dipoles, fed in quadrature, the orthogonal dipoles located near the aperture of the waveguide operating close to its dominant mode cut off frequency. | 06-27-2013 |
20130072898 | METHOD AND SYSTEM FOR SUSTAINED-RELEASE OF SCLEROSING AGENT - Methods and systems for treating pleural disease comprising a providing a low dosage of a sclerosing agent over a period of time. Certain examples include catheter with a sclerosing agent that is inserted into the pleural space. The sclerosing agent is released in a sustained-release manner over a period of time to achieve diffuse pleurodesis of the pleural layers. | 03-21-2013 |
20120305070 | CYLOMETALATED DYE COMPLEXES AND THEIR USE IN DYE-SENSITIZED SOLAR CELLS - The present invention provides a modular approach to preparing a large array of substituted cyclometalated compounds which behave as dyes having intense absorbance bands in the visible spectrum. The compounds include at least one terpyridine-type ligand (tpy) and one cyclometalated tridentate ligand having the bonding motif N,C,N′ or C,N, N′. In particular, compounds of formula (I) and formula (II), as shown, where M and R | 12-06-2012 |
20120259572 | SYSTEM AND METHOD FOR GYROSCOPE ERROR ESTIMATION - Methods and systems for compensating for gyroscopic errors. A system uses magnetometers to detect and measure a magnetic field local to a personal navigation device. When the local magnetic field is quasi-static, the rate of change of the magnetic field is combined with the rotational rate of change of the device. This generates an estimated gyroscope error. The error can then be used to correct for time-varying inherent gyroscope errors. | 10-11-2012 |
20110287008 | INHIBITION OF EMMPRIN TO TREAT MULTIPLE SCLEROSIS - The present invention provides new methods for the prevention of migration of leukocytes into the CNS. These methods, which rely on inhibition of EMMPRIN activity or expression, can be used to treat or slow the onset of diseases such as multiple sclerosis and EAE. | 11-24-2011 |
20110213234 | System and method for using orthogonally-coded active source signals for reflected signal analysis - A system and method for using orthogonally-coded active source signals for reflected signal analysis, such as in seismic exploration, sonar, and/or ultrasound applications. One method comprises inputting an orthogonally-coded active source signal to a target site, where the orthogonally-coded active source signal is sufficiently random to not interfere with a delayed version of itself. A reflected signal is received from the target site, and based at least in part on the sufficiently random orthogonal coding of the active source signal, a determination is made whether the received signal is a reflection of the input active source signal. | 09-01-2011 |
20100222841 | FEEDBACK CONTROLLED GASTRO-INTESTINAL STIMULATION - Neural Gastric Electrical Stimulation (NGES) is a new method for invoking gastric contractions under microprocessor control. However, optimization of this technique using feedback mechanisms to minimize power consumption and maximize effectiveness has been lacking. An apparatus and method are provided for inducing controlled gastro paresis. The apparatus comprises a contraction sensor, a stomach contraction generator, and a controller. The contraction sensor is responsive to circumferential contractions of the stomach, and outputs a signal indicative of a circumferential contraction. The stomach contraction generator induces a circumferential contraction upon receipt of an electrical signal from the controller. The controller sends the electrical signal to the generator upon receipt of the output signal from the sensor. The method comprises the steps of sensing a circumferential contraction of the stomach, and invoking a circumferential contraction of the stomach in response to sensing the circumferential contraction. | 09-02-2010 |
20100221463 | Integrated Encapsulation for MEMS Devices - In one general aspect, methods and articles of manufacture for creating micro-structures are disclosed. In one embodiment, the micro-structures are configured to provide a desired level of hermiticity to other micro-sized devices, such as MEMS and microfluidic devices. In one embodiment, the microstructures are formed from a single species of photoresist, where the photoresist is lithographically patterned to encapsulate the micro-sized device. In general, the ability to form an encapsulating micro-structure from a single photoresist relies in part on applying variable light doses to a later of photoresist to affect a desired level of cross-linking within the photoresist. | 09-02-2010 |
20100145190 | Traveling-Wave Antenna - Embodiments of endfire aperture-based traveling-wave antennas are described. For example, an embodiment, including a Vivaldi antenna, may have a director incorporated into the aperture region of the antenna to provide enhanced radiation directivity. The director may be a shaped dielectric that interacts with an electromagnetic field to reduce the divergence of the resultant beam as it exits the antenna. Additional dielectric substrate layers may be stacked on both sides of the antenna in order to balance the dielectric loading between the different conductors. The dielectric substrates may also eliminate contact between the antenna metallization and the lossy environment. Certain disclosed Vivaldi antennas may be used in tissue screening applications. | 06-10-2010 |
20100109435 | Linear Voltage Regulator with Multiple Outputs - Systems, methods, and apparatuses that may be employed to generate multiple, regulated, isolated power supply voltages are disclosed. In a first implementation, a system includes a circuit configured to supply a plurality of regulated supply voltages. The circuit may include a voltage regulator that can include a first transistor, where the first transistor can be configured to supply a first regulated supply voltage. The circuit may further include a second transistor, operably coupled to the first transistor, where the second transistor can be configured to supply a second regulated supply voltage. | 05-06-2010 |
20100066378 | Current Mirror Potentiostat - Systems, methods, and apparatuses for measuring current flow in an electrochemical cell are disclosed. A system includes a circuit configured to output a mirrored value of an electrical current flowing through an electrochemical cell. The system may also include a voltage controller, coupled to one or more electrodes of the electrochemical cell, for controlling the voltage difference between at least two electrodes of the electrochemical cell. The system may further include a current replication circuit coupled to the voltage controller or the electrochemical cell. The current replication circuit generates a mirrored current of the electrical current flowing in the electrochemical cell. The replicated current may be measured or processed with different circuits and methods to output the current flowing through the electrochemical cell. | 03-18-2010 |
20100065268 | IN SITU HEAVY OIL AND BITUMEN RECOVERY PROCESS - The present invention is directed to an in situ reservoir recovery process that uses a horizontal well located near the top of a reservoir and an inclined production well to extract bitumen or heavy oil from a reservoir. In a first stage, the top well is used for cold production of reservoir fluids to the surface, in which, reservoir fluids are pumped to the surface in the absence of stimulation by steam or other thermal and/or solvent injection. A lower production well is drilled into the formation below the top well. The top well is converted to an injection well or, if no cold production then a top well is drilled as an injector well. A portion of the bottom well is inclined so that one end of the incline is closer to the injector well than the other end of the incline. In the process, steam circulation creates a heated zone at the point of the two wells that are closest together in the reservoir. | 03-18-2010 |
20100019963 | VEHICULAR NAVIGATION AND POSITIONING SYSTEM - A vehicular navigation and positioning method and system includes a GNSS receiver, an inertial navigation system and on-board vehicular sensors. Available data is integrated by a Kalman filter and vehicle position, velocity and attitude is updated as a result. | 01-28-2010 |
20100007568 | Antenna with Balun - A balun, generally including a substrate, a microstrip conductor, and a parallel strip conductor is described, where a characteristic impedance of the balun is substantially constant at each cross-sectional point along a length of the balun. A transverse electromagnetic horn antenna can transmit and receive ultra-wide band pulses, and includes a first metal conductor and a second metal conductor, where a characteristic impedance of the first and second conductor varies over a length of the antenna in a controlled means. | 01-14-2010 |
20090245213 | Efficient Quality of Service (QoS) Scheduling in OFDMA Wireless Networks - A system and methods for A method for efficient Quality of Service (QoS) scheduling in OFDMA wireless networks are presented. In one embodiment, the method includes determining a number of time slots to allocate to one of a plurality of wireless mobile stations according to a linear solution that satisfies one or more data access requirements and maximizes base station utilization. The method may also include adjusting the linear solution in response to a determination that a power consumption value exceeds a predetermined threshold value. Additionally, the method may include granting the one or more mobile stations access to the time slots in accordance with the linear solution. | 10-01-2009 |
20090238426 | System and Methods for Identifying an Object within a Complex Environment - A signal processing technique includes extracting object features, an object response classification, and a reconstruction of the object estimate. In selected embodiments, an optional step that improves the estimate of the object response is included in the signal processing technique. In one implementation of the signal processing technique, reflections from the surrounding environment are removed from the response of a target object to permit the identification, localization, and imaging of the target. In select implementations, the technique can be used to image tumors located within breast tissue. | 09-24-2009 |
20090214479 | ATTENUATED REOVIRUS - Compositions and methods are provided that relate to an attenuated reovirus exhibiting oncolytic activity toward cancer cells while displaying reduced lytic activity toward non-malignant cells. Exemplified is an attenuated human reovirus derived from persistently infected fibrosarcoma cells that lacks wild-type reovirus S1 and S4 genes and consequently lacks a detectable reoviral outer capsid σ1 protein and expresses a mutated reoviral outer capsid σ3 protein. | 08-27-2009 |
20090170900 | DOSING REGIMEN FOR WEIGHT LOSS - Disclosed are dosing regimens and methods for the treatment of obesity, overweight and/or overeating in mammals comprising administering to the mammal a pharmaceutically effective amount of a CB1 receptor antagonist as a unit dosage according to a continuous schedule having a dosing interval selected from the group consisting of once-weekly dosing, twice-weekly dosing, thrice-weekly dosing, biweekly and bimonthly. | 07-02-2009 |
20090025725 | TRANSIENT INTERVENTION FOR MODIFYING THE BREATHING OF A PATIENT - A method for modifying the breathing of a patient while the patient is experiencing sleep apnea, for example Cheyne Stokes breathing. An instantaneous pulmonary ventilation of a patient is monitored. Limit cycle behavior of the instantaneous pulmonary ventilation is identified. A transient intervention is applied to the patient during a phase of a limit cycle of the instantaneous pulmonary ventilation. The transient intervention has an effect on a breathing state of the patient. | 01-29-2009 |
20080213908 | FLAME DETECTOR - Improved operating modes of a micro counter-current flame ionization detector (μFID) are demonstrated. By operating the flame inside the end of a capillary gas chromatography (GC) column, the effective cell volume enclosing the flame is considerably reduced and results in significantly lower gas flows being required to produce optimal sensitivity from the stable flame. In a post-column μFID arrangement, a very lean flame is now situated on the end of a stainless steel capillary delivering 10 mL/min of hydrogen, which is opposed by a counter-current flow of only 20 mL/min of oxygen. The μFID detection limit obtained in this stable, oxygen-rich counter-current flame mode is 7×10 | 09-04-2008 |
20080213801 | Monomeric streptavidin muteins - The invention includes a streptavidin mutein having at least one mutation chosen to cause one or more of steric hindrance, charge repulsion, or improvement of solubility by changing interfacial hydrophobic residues to less hydrophobic or hydrophilic residues. The mutein may exist in monomeric form even in the presence of biotin, and reversibly binds to biotin. The invention also includes polynucleotides encoding such muteins, expression systems and host cells for producing such muteins. The invention also includes a method of capturing biotinylated molecules using the muteins of the invention. | 09-04-2008 |